Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $0.08 in the prior trading day, Lyra Therapeutics Inc (NASDAQ: LYRA) closed at $0.10, up 20.38%. In other words, the price has increased by $20.38 from its previous closing price. On the day, 1.33 million shares were traded. LYRA stock price reached its highest trading level at $0.1083 during the session, while it also had its lowest trading level at $0.0834.
Ratios:
Our goal is to gain a better understanding of LYRA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.41 and its Current Ratio is at 3.41. In the meantime, Its Debt-to-Equity ratio is 2.97 whereas as Long-Term Debt/Eq ratio is at 2.61.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on May 07, 2024, Downgraded its rating to Hold and sets its target price to $0.50 from $10 previously.
On May 07, 2024, H.C. Wainwright Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $12 to $2.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 09 ’25 when Palasis Maria bought 39,567 shares for $0.09 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LYRA now has a Market Capitalization of 6732997 and an Enterprise Value of 535993. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.40 while its Price-to-Book (P/B) ratio in mrq is 0.58. Its current Enterprise Value per Revenue stands at 0.349 whereas that against EBITDA is -0.009.
Stock Price History:
The Beta on a monthly basis for LYRA is 0.20, which has changed by -0.9806452 over the last 52 weeks, in comparison to a change of 0.059571505 over the same period for the S&P500. Over the past 52 weeks, LYRA has reached a high of $5.77, while it has fallen to a 52-week low of $0.08. The 50-Day Moving Average of the stock is -39.72%, while the 200-Day Moving Average is calculated to be -55.44%.
Shares Statistics:
The stock has traded on average 1.11M shares per day over the past 3-months and 2178680 shares per day over the last 10 days, according to various share statistics. A total of 65.52M shares are outstanding, with a floating share count of 54.86M. Insiders hold about 16.73% of the company’s shares, while institutions hold 37.95% stake in the company. Shares short for LYRA as of 1743379200 were 2412416 with a Short Ratio of 2.18, compared to 1740700800 on 1877045. Therefore, it implies a Short% of Shares Outstanding of 2412416 and a Short% of Float of 4.5900002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
